H-Orn(Boc)-OMe · HCl

H-Orn(Boc)-OMe · HCl is a protected ornithine derivative presented as the methyl ester hydrochloride salt, featuring a chiral amino acid backbone with an N-Boc (tert-butoxycarbonyl) protected α-amino group and a methyl ester at the carboxyl position. The side chain contains a primary amine typical of ornithine, which is present in a salt-form environment that can influence solubility and coupling behavior. The Boc carbamate provides acid-labile protection for controlled deprotection during peptide assembly, while the ester functionality enables downstream transformations such as transesterification or conversion to activated carboxylic acid derivatives. The overall structure functions as a chiral, protected amino acid intermediate suitable for peptide building block preparation and for constructing amine-bearing ornithine analogs with defined stereochemistry.

1. Protected Amino Acids

H-Orn(Boc)-OMe · HCl is used in protected amino acid synthesis workflows where orthogonally protected functionality is required for stepwise assembly. The N-Boc group stabilizes the α-amino moiety during ester manipulation and peptide coupling, while the methyl ester can be carried through synthesis as a protected carboxyl equivalent before conversion to an acid or activated derivative. The side-chain primary amine enables further derivatization or selective protection strategies, supporting controlled orthogonality between α- and side-chain functionalities. The hydrochloride salt form can improve handling in synthetic sequences that rely on amine protonation states. This compound therefore serves as a practical intermediate for protected amino acid chemistry and controlled functional group programming.

2. Peptide Synthesis

H-Orn(Boc)-OMe · HCl is applied as an ornithine-based peptide building block in peptide coupling chemistry and protected peptide fragment construction. The Boc-protected α-amino group participates in standard peptide bond formation after Boc removal under acid conditions, while the methyl ester can be converted to the corresponding carboxylate form or activated for C-terminal incorporation depending on the coupling design. The side-chain primary amine supports the preparation of polyamine-containing peptides, including sequences that require lysine/ornithine-like reactivity for later conjugation or cyclization. The defined stereochemistry at the α-carbon helps maintain consistency across peptide libraries and analog series. This compatibility with Boc-based protection logic makes H-Orn(Boc)-OMe · HCl suitable for assembling ornithine-containing peptides and peptide fragments used in biochemical research.

3. Side-Chain Functionalization

H-Orn(Boc)-OMe · HCl is utilized in side-chain functionalization programs where the ornithine primary amine is the reactive handle for post-assembly modification. The presence of an N-Boc protected α-amino group helps prevent undesired coupling at the backbone during selective transformations of the side-chain amine. The methyl ester can be retained during early derivatization steps and later converted to carboxylic acid derivatives for further coupling or for generating defined C-terminal motifs. The hydrochloride salt environment can facilitate controlled amine reactivity and solubility during derivatization and purification. Downstream products can include N-substituted ornithine analogs, amide-linked conjugates, or precursors for cyclization chemistry, supporting synthetic routes that depend on precise side-chain programming.

4. Peptidomimetics And SAR Studies

H-Orn(Boc)-OMe · HCl is applied in peptidomimetic and SAR-focused synthesis where ornithine-like cationic spacing and amine density are used to tune molecular recognition. The chiral amino acid framework and protected functional groups enable incorporation into analog scaffolds while maintaining stereochemical fidelity at the α-center. The Boc-protected α-amino group supports controlled deprotection to generate a coupling-ready amine, and the side-chain primary amine can be diversified to introduce urea, amide, sulfonamide, or other nitrogen-containing motifs that modulate polarity and hydrogen bonding. The methyl ester can function as a handle for C-terminal modifications that influence conformational preferences and physicochemical properties. This makes H-Orn(Boc)-OMe · HCl suitable for constructing structure-activity relationship libraries of amino acid-derived mimetics and related research intermediates.

5. Pharmaceutical Intermediate Preparation

H-Orn(Boc)-OMe · HCl is relevant to pharmaceutical intermediate preparation where protected amino acid building blocks are required for scalable synthetic sequences. The orthogonal protection pattern, with acid-labile Boc on the α-amino group and a carboxyl methyl ester, supports route design in which selective deprotection and subsequent activation steps can be scheduled to minimize side reactions. The side-chain primary amine can be protected or transformed into downstream functional groups that align with drug-like pharmacophore requirements, including polyamine-mimicking motifs and nitrogen-rich linkers. The hydrochloride salt form can improve crystallization behavior and handling for process chemistry stages that depend on stable solid forms. This compound can therefore be employed as a chiral, functionalized intermediate for manufacturing-oriented synthesis of amino acid-derived intermediates and fine chemicals.

1. Investigating Potential Interactions Between Neurohypophyseal Peptides, their Drug Analogs, and Coagulation Factor VIII

2. Sex differences in oxidative stress level and antioxidative enzymes expression and activity in obese pre-diabetic elderly rats treated with metformin or liraglutide

3. The effect of B-type allatostatin neuropeptides on crosstalk between the insect immune response and cold tolerance

4. Constitutive and inflammation-dependent antimicrobial peptides produced by epithelium are differentially processed and inactivated by the commensal Finegoldia magna and the pathogen Streptococcus pyogenes

5. Quantitative Analysis of Ligands Effects on Bioefficacy of Nanoemulsion encapsulating Depigmenting Active